Nucleotide-binding oligomerization domain-2 modulates specific TLR pathways for the induction of cytokine release

Journal of Immunology

Volumn 174, Issue 10, 2005, Pages 6518-6523

  Netea, Mihai G ^a   Ferwerda, Gerben ^a   De Jong, Dirk J ^a   Jansen, Trees ^a   Jacobs, Liesbeth ^a   Kramer, Matthijs ^a   Naber, Ton H J ^a   Drenth, Joost P H ^a   Girardin, Stephen E ^b   Kullberg, Bart Jan ^a   Adema, Gosse J ^a   Van Der Meer, Jos W M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CYTOKINE; INTERLEUKIN 10; PEPTIDOGLYCAN; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IMMUNOMODULATION; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TH1 CELL;

EID: 20844454920     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.10.6518     Document Type: Article

References (31)

1. Hugot, J.-P., P. Laurent-Puig, C. Gower-Rousseau, J. M. Olson, J. C. Lee, L. Beaugerie, I. Naom, J. L. Dupas, A. Van Gossum, M. Orholm, et al. 1996. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 379: 821-823.
2. Hugot, J.-P., M. Chamaillard, H. Zouali, S. Lesage, J.-P. Cezard, J. Belaiche, S. Almer, C. Tysk, C. A. O'Morain, M. Gassull, et al. 2001. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411: 599-603.
3. Hampe, J., J. Grebe, S. Nikolaus, C. Solberg, P. J. P. Croucher, S. Mascheretti, J. Jahnsen, B. Moum, B. Klump, M. Krawczak, et al. 2002. Association of NOD2 (CARD15) genotype with clinical course of Crohn's disease: a cohort study. Lancet 359: 1661-1665.
4. Ogura, Y., D. K. Bonen, N. Inohara, D. L. Nicolae, F. F. Chen, R. Ramos, H. Britton, T. Moran, R. Karalluskas, R. H. Duerr, et al. 2001. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411: 603-606.
5. Gutierrez, O., C. Pipaon, N. Inohara, A. Fontalba, Y. Ogura, F. Prosper, G. Nunez, and J. L. Fernandez-Luna. 2002. Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-κB activation. J. Biol. Chem. 277: 41701-41705.
6. Inohara, N., Y. Ogura, F. F. Chen, A. Muto, and G. Nunez. 2001. Human Nod1 confers responsiveness to bacterial lipopolysaccharides. J. Biol. Chem. 276: 2551-2554.
7. Girardin, S. E., I. G. Boneca, J. Viala, M. Chamaillard, A. Labigne, G. Thomas, D. J. Philpott, and P. J. Sansonetti. 2003. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278: 8869-8872.
8. Inohara, N., Y. Ogura, A. Fontalba, O. Gutierrez, F. Pons, J. Crespo, K. Fukase, S. Inamura, S. Kusumoto, M. Hashimoto, et al. 2003. Host recognition of bacterial muramyl dipeptide mediated through Nod2. J. Biol. Chem. 278: 5509-5512.
9. Netea, M. G., B. J. Kullberg, D. de Jong, B. Francke, T. Sprong, T. Naber, J. P. H. Drenth, and J. W. M. Van der Meer. 2004. NOD2 mediates antiinflammatory signals induced by TLR2-ligands: implications for Crohn's disease. Eur. J. Immunol. 34: 2052-2059.
10. Watanabe, T., A. Kitani, P. J. Murray, and W. Strober. 2004. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat. Immunol. 5: 800-808.
11. Endres, S., R. Ghorbani, G. Lonnemann, J. W. M. Van der Meer, and C. A. Dinarello. 1988. Measurement of immunoreactive interleukin-1β from human mononuclear cells: optimization of recovery, intrasubject consistency, and comparison with interleukin-1α and tumor necrosis factor. Clin. Immunol. Immunopathol. 49: 424-438.
12. Takeuchi, O., K. Hoshino, T. Kawai, H. Sanjo, H. Takada, T. Ogawa, K. Takeda, and S. Akira. 1999. Differentia] roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 11: 443-451.
13. Kullberg, B. J., J. W. Van't Wout, C. Hoogstraten, and R. Van Furth. 1993. Recombinant interferon-γ enhances resistance to acute disseminated Candida albicans infection in mice. J. Infect. Dis. 168: 436-443.
14. Drenth, J. P. H., S. H. M. Van Uum, M. Van Deuren, G. J. Pesman, J. Van der Ven-Jongekrijg, and J. W. M. Van der Meer. 1995. Endurance run increases circulating TL-6 and IL-1ra but downregulates ex vivo TNF-α and IL-1β production. J. Appl. Physiol. 79: 1497-1503.
15. Netea, M. G., P. N. M. Demacker, B. J. Kullberg, O. C. Boerman, I. Verschueren, A. F. H. Stalenhoef, and J. W. M. Van der Meer. 1996. Low-density-lipoprotein receptor deficient mice are protected against lethal endotoxinemia and severe Gram-negative infections. J. Clin. Invest. 97: 1366-1372.
16. Lien, E., T. K. Means, H. Heine, A. Yoshimura, S. Kusumoto, K. Fukase, M. J. Menton, M. Oikawa, M. Qureshi, B. Monks, et al. 2000. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J. Clin. Invest. 105: 497-504.
17. Takeuchi, O., K. Hoshino, and S. Akira. 2000. TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus infection. J. Immunol. 165: 5392-5396.
18. Girardin, S. E., and D. J. Philpott. 2004. The role of peptidoglycan recognition in innate immunity. Eur. J. Immunol. 34: 1777-1782.
19. Pauleau, A. L., and P. J. Murray. 2003. Role of NOD2 in the response of macrophages to Toll-like receptor agonists. Mol. Cell. Biol. 23: 7531-7539.
20. Wolfert, M. A., T. F. Murray, G. J. Boons, and J. N. Moore. 2002. The origin of the synergistic effect of muramyl dipeptide with endotoxin and peptidoglycan. J. Biol. Chem. 277: 39179-39186.
21. Yang, S., R. Tamai, S. Akashi, O. Takeuchi, S. Akira, S. Sugawara, and H. Takada. 2001. Synergistic effect of muramyl dipeptide with lipopolysaccharide or lipoteichoic acid to induce inflammatory cytokines in human monocytic cells in culture. Infect. Immun. 69: 2045-2053.
22. Targan, S. R., S. B. Hanauer, S. J. van Deventer, L. Mayer, D. H. Present, T. Braakman, K. L. DeWoody, T. F. Schaible, and P. J. Rutgeerts. 1997. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease. N. Engl. J. Med. 337: 1029-1035.
23. Wehkamp, J., J. Harder, M. Weichenthal, E. Schaffeler, M. Schlee, K. R. Herrlinger, A. Stallmach, F. Noack, P. Fritz, J. M. Schroder, et al. 2004. NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal α-defensin expression. Gut 53: 1658-1664.
24. Kobayashi, M., M. N. Kweon, H. Kuwata, R. D. Schreiber, H. Kiyono, K. Takeda, and S. Akira. 2003. Toll-like receptor-dependent production of IL-12p40 causes chronic enterocolitis in myeloid cell-specific Stat3-deficient mice. J. Clin. Invest. 111: 1297-1308.
25. Obermeier, F., N. Dunger, L. Deml, H. Herfarth, J. Scholmerich, and W. Falk. 2002. CpG motifs of bacterial DNA exacerbate colitis of dextran sulfate sodium-treated mice. Eur. J. Immunol. 32: 2084-2092.
26. Traub, S., N. Kubasch, S. Morath, M. Kresse, T. Hartung, R. R. Schmidt, and C. Hermann. 2004. Structural requirements of synthetic muropeptides to synergize with lipopolysaccharide in cytokine induction. J. Biol. Chem. 279: 8694-8700.
27. Rachmilewitz, D., K. Katakura, F. Karmeli, T. Hayashi, C. Reinus, B. Rudensky, S. Akira, K. Takeda, J. Lee, K. Takabayashi, et al. 2004. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 126: 520-528.
28. Torok, H.-P., J. Glas, L. Tonenchi, G. Bruennler, M. Folwaczny, and C. Folwaczny. 2004. Crohn's disease is associated with a Toll-like receptor-9 polymorphism. Gastroenterology 127: 365-366.
29. Maaser, C., J. Heidemann, C. van Eiff, A. Lugering, T. W. Spahn, D. G. Binion, W. Domschke, N. Lugering, and T. Kucharzik. 2004. Human intestinal microvascular endothelial cells express Toll-like receptor 5: a binding partner for bacterial flagellin. J. Immunol. 172: 5056-5062.
30. Lodes, M. J., Y. Cong, C. O. Elson, R. Mohamath, C. J. Landers, S. R. Targan, M. Fort, and R. M. Hershberg. 2004. Bacterial flagellin is a dominant antigen in Crohn disease. J. Clin. Invest. 113: 1296-1306.
31. Kobayashi, K., N. Inohara, L. D. Hernandez, J. E. Galen, G. Nunez, C. A, Janeway, R. Medzhitov, and R. A. Flavell. 2002. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature 416: 194-199.